Free Trial

GoHealth (NASDAQ:GOCO) Trading 1.8% Higher - What's Next?

GoHealth logo with Finance background

GoHealth, Inc. (NASDAQ:GOCO - Get Free Report) shares shot up 1.8% during mid-day trading on Thursday . The stock traded as high as $11.58 and last traded at $11.50. 17,180 shares traded hands during mid-day trading, a decline of 9% from the average session volume of 18,867 shares. The stock had previously closed at $11.30.

Analyst Ratings Changes

Separately, Royal Bank of Canada reissued a "sector perform" rating and issued a $13.00 price target on shares of GoHealth in a research note on Monday, October 21st.

Read Our Latest Research Report on GOCO

GoHealth Price Performance

The company has a 50 day simple moving average of $10.62 and a 200-day simple moving average of $10.22. The stock has a market cap of $272.58 million, a price-to-earnings ratio of -3.40 and a beta of 1.66. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 1.72.

Institutional Trading of GoHealth

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Empowered Funds LLC increased its position in shares of GoHealth by 5.1% in the third quarter. Empowered Funds LLC now owns 22,048 shares of the company's stock valued at $207,000 after acquiring an additional 1,072 shares during the last quarter. Bank of New York Mellon Corp increased its position in shares of GoHealth by 16.1% in the second quarter. Bank of New York Mellon Corp now owns 12,982 shares of the company's stock valued at $126,000 after acquiring an additional 1,802 shares during the last quarter. Geode Capital Management LLC increased its position in shares of GoHealth by 3.2% in the third quarter. Geode Capital Management LLC now owns 103,735 shares of the company's stock valued at $973,000 after acquiring an additional 3,205 shares during the last quarter. Renaissance Technologies LLC increased its position in GoHealth by 22.0% during the second quarter. Renaissance Technologies LLC now owns 18,272 shares of the company's stock worth $178,000 after buying an additional 3,300 shares during the last quarter. Finally, Barclays PLC increased its position in GoHealth by 83.9% during the third quarter. Barclays PLC now owns 9,580 shares of the company's stock worth $89,000 after buying an additional 4,372 shares during the last quarter. Institutional investors and hedge funds own 24.21% of the company's stock.

GoHealth Company Profile

(Get Free Report)

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.

Recommended Stories

Should you invest $1,000 in GoHealth right now?

Before you consider GoHealth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoHealth wasn't on the list.

While GoHealth currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines